Overview

Risk Factor Control Before Orthopedic Surgery

Status:
Terminated
Trial end date:
2018-04-02
Target enrollment:
Participant gender:
Summary
This trial is designed to determine the best preoperative management strategy for patients undergoing orthopedic surgery.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Atorvastatin
Atorvastatin Calcium
Lisinopril
Metoprolol